60 Degrees Pharmaceuticals partners with Tulane to study lyme treatment
Go back to 60 Degrees Pharmaceuticals partners with Tulane to study lyme treatment| (NASDAQ: SXTP) | Delayed: 1.51 -0.01 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.52 | 52 Week High | $ | |||
| Open | $1.55 | 52 Week Low | $ | |||
| Day High | $1.55 | P/E | N/A | |||
| Day Low | $1.47 | EPS | $ | |||
| Volume | 10,088 | |||||
| (NASDAQ: SXTPW) | Delayed: 0.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $ | |||
| Open | $0.03 | 52 Week Low | $ | |||
| Day High | $0.03 | P/E | N/A | |||
| Day Low | $0.03 | EPS | $ | |||
| Volume | 2,102 | |||||

